Hannah Furfaro was a news writer at Spectrum from 2017 to 2019. Before that, Hannah was an investigative reporting fellow at Columbia University. She previously worked at The Wall Street Journal, The Fresno Bee and the Associated Press. Her work has also appeared in The Guardian and Audubon Magazine.
Hannah Furfaro
From this contributor
How aripiprazole’s promise for treating autism fell short
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.
How aripiprazole’s promise for treating autism fell short
Sleep problems in autism, explained
Many people with autism have difficulty falling and staying asleep, but there may be ways to help them.
Autistic girls’ brains show distinct anatomical features
Nerve fiber tracts in the brains of autistic girls appear more fragmented than those of typical girls’. Autistic boys’ brains, meanwhile, look like those of typical boys.
Autistic girls’ brains show distinct anatomical features
Beyond the bench: A conversation with Annie Ciernia
Annie Ciernia describes the greenhouse origins of her scientific career and why a unicorn makes a good lab mascot.
Beyond the bench: A conversation with Annie Ciernia
Small sponge may sop up maternal antibody tied to autism
Researchers have created a microscopic particle that traps immune molecules found in a woman that are linked to autism in her child.
Small sponge may sop up maternal antibody tied to autism
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.